Download PDF
Thromb Haemost 1971; 25(03): 580-589
DOI: 10.1055/s-0038-1654331
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Separation and Characterization of Two Fibrinolytic Inhibitors from Human Placenta

M Uszynski
1   Haematological Research Laboratory, Dept. IX, Ullevål Hospital, Oslo, Norway
2   First Dept. of Obstetrics and Gynaecology, Medical School of Bialystok, Poland
,
U Abildgaard
1   Haematological Research Laboratory, Dept. IX, Ullevål Hospital, Oslo, Norway
2   First Dept. of Obstetrics and Gynaecology, Medical School of Bialystok, Poland
› Author Affiliations
Further Information

Publication History

Publication Date:
28 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

Procedures for the separation of two inhibitors of the activation of plasminogen to plasmin by urokinase are described. Tissue thromboplastin was removed by adsorption to Al(0H)3 gel followed by ultracentrifugation. Plasminogen, plasminogen activator, a coagulation inhibitor and hemoglobin were removed by ion exchange chromatography (CM- or DEAE-Sephadex with NaCl gradients). The minor UK inhibitor is a relative basic protein with a pI of about 5.8. The major inhibitor was purified further by isoelectric focusing, preparative electrophoresis in polyacrylamide gel, and gel filtration. This inhibitor has α1-motility, the pI is about 5.2, and the molecular weight about 100,000. It inactivates urokinase progressively, but does not inhibit streptokinase, plasmin or thrombin.

 

  • References

  • 1 Abildgaard, UPurification of two progressive antithrombins of human plasma. Scand. J. clin. Invest 19: 190 1967;
    CrossrefPubMedGoogle Scholar
  • 2 Abildgaard U. Highly purified antithrombin III with heparin cofactor activity prepared by disc electrophoresis. Scand. J. clin. Lab. Invest 21: 89 1968;
    CrossrefPubMedGoogle Scholar
  • 3 Andrews P. Molecular-sieve chromatography. Brit. med. Bull 22: 109 1966;
    CrossrefPubMedGoogle Scholar
  • 4 Berg W, Korsan-Bengtsen K, Ygge I. Human and bovine plasminogenfree thrombin, purified by means of gel filtration and ion exchange chromatography. Thrombos. Diathes. haemorrh. (Stuttg) 15: 501 1966;
    PubMedGoogle Scholar
  • 5 Berg W, Korsan-Bengtsen K, Ygge I. Preparation of human plasminogen suitable as substrate for quantitative determination of plasminogen activators. Thrombos. Diathes. haemorrh. (Stuttg) 15: 501 1966; b
    PubMedGoogle Scholar
  • 6 Bergstrom K, Wallen P. Removal of contaminating plasminogen from purified bovine fibrinogen. ArkivKemi 17: 503 1961;
    PubMedGoogle Scholar
  • 7 Brahman P, Astrup T. Selective inhibition in human pregnancy blood of urokinase induced fibrinolysis. Scand. J. clin. Lab. Invest 15: 603 1963;
    CrossrefPubMedGoogle Scholar
  • 8 Clarice N, O’Meara R. A. Q. Intracellular location of thromboplastic activity in the cells of human chorion. Brit. J. Haemat 12: 536 1966;
    CrossrefPubMedGoogle Scholar
  • 9 Davis B. J. Disc electrophoresis II. Method and application to human serum proteins. Ann. N.Y. Acad. Sei 121: 404 1964;
    PubMedGoogle Scholar
  • 10 Goa J. A micro biuret method for protein determination. Scand. J. clin. Lab. Invest 05: 218 1953;
    CrossrefPubMedGoogle Scholar
  • 11 Hedner, Ulla Nilsson I. n. gaMarie, Jacobsen G. D. Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity. Scand. J. clin. Lab. Invest 04: 329 1970;
    PubMedGoogle Scholar
  • 12 Helle I. The inhibitory effect of large concentrations of streptokinase as related to proteolytic activity and proactivator function of human euglobulin. Scand. J. Haemat 01: 240 1964;
    PubMedGoogle Scholar
  • 13 Hjort P. F. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Thesis. Scand. J. clin. Lab. Invest. 9, Suppl. 27 1957
    PubMedGoogle Scholar
  • 14 Januszo T, Buluk K, Uszynska-Folejewska R, Uszynski M. Measurement of the inhibitor of plasminogen activation in the euglobulin test. Pol. med. J 04: 914 1966;
    PubMedGoogle Scholar
  • 15 Jovin T, Ghrambach A, Naughton M. A. An apparatus for preparative temperature- regulated polyacrylamide gel electrophoresis. Analyt. Biochem 09: 351 1964;
    CrossrefPubMedGoogle Scholar
  • 16 Kawano T, Morimoto K, TJemura Y. Urokinase inhibitor in human placenta. Nature (Lond) 217: 253 1968;
    CrossrefPubMedGoogle Scholar
  • 17 Kawano T, Morimoto K, Uemura Y. Partial purification and properties of urokinase inhibitor from human placenta. J. Biochem 03: 333 1970;
    PubMedGoogle Scholar
  • 18 Loeb J. Le cofacteur plasmatique de l’heparine et ses rapports avec l’antithrombine. Arch. Sei. physiol 10: 129 1956;
    PubMedGoogle Scholar
  • 19 Martin R. G, Ames B. N. A method for determining the sedimentation behavior of enzymes : Application to protein mixtures. J. biol. Chem 236: 1372 1961;
    PubMedGoogle Scholar
  • 20 Paraskevas, Maria Nilsson IngaMarie, Martinsson Gunilla. A method for determining serum inhibitors of plasminogen activation. Scand. J. clin. Lab. Invest 14: 138 1962;
    CrossrefPubMedGoogle Scholar
  • 21 Permin P. M. The fibrinolytic activator in animal tissue. Acta physiol, scand 21: 159 1950;
    CrossrefPubMedGoogle Scholar
  • 22 Semar M, Skoza L, Johnson A. J. Partial purification and properties of a plasminogen activator from human erythrocytes. J. clin. Invest 10: 1777 1969;
    PubMedGoogle Scholar
  • 23 Shaper A. G. Fibrinolytic activity in pregnancy, during parturition, and in the puerperium. Lancet II: 874 1966;
    PubMedGoogle Scholar
  • 24 Todd A. S. Histological activation of fibrinolysin activator. J. Path. Bact 78: 281 1959;
    CrossrefPubMedGoogle Scholar
  • 25 Uszynski M, Uszynska-Folejewska R. Plasminogen activator and urokinase inhibitor in myometrium, placenta and amniotic fluid. Amer. J. Obstet. Gynec 07: 1041 1969;
    PubMedGoogle Scholar
  • 26 Uszynski M, Abildgaard U. Purification and properties of two fibrinolytic inhibitors from human placenta. Int. Congr. Hemat., München 1970. Symposium antifibrinolytic substances, Addendum abstract sheet..
    PubMedGoogle Scholar
  • 27 Uszynski M, Godal H. G. An inhibitor of factor VII from human placenta. Scand. J. Haemat. (In press.)
    PubMedGoogle Scholar
  • 28 Vesterberg O, Svensson H. Isoelectric fractionation, analysis and characterization of ampholytes in natural pH gradients. IV. Further studies on the resolving power in connection with separation of myoglobin. Acta chem. scand 20: 820 1966;
    CrossrefPubMedGoogle Scholar